SÜSS MicroTec SE

Quarterly Report • May 8, 2025

Quarterly Report January 1 – March 31 2025

Growing Innovation

Key figures

SUSS Group

for the period from January 1 to March 31, 2025

in € m i l l ion	Q 1 2 0 2 5	Q 1 2 0 2 4	C han g e
Bu ine dev lop t s ss e me n
Or der inta ke	8 8. 1	9 8. 3	-1 0. 4 %
Or der boo k a f Ma h 3 1 s o rc	3 9 2. 7	4 5 6. 9	-1 4. 1 %
Sa les	2 3. 2 1	9 3. 5	3 8 1. % +
Gro f it ss p ro	4 6. 7	3 6. 6	2 7. 6 % +
Gro f it m in ss p ro arg	3 7. 9 %	3 9. 1 %	-1. 2 %- Po ints
Co f sa les st o	7 6. 5	5 6. 9	3 4. 4 % +
Res h a d dev lop nt e ear c n e me xp ens es	1 0. 9	9. 2	1 8. % 5 +
E B I T D A	2 2. 3	1 6. 7	3 3. 5 % +
E B I T D A m in arg	1 8. 1 %	1 7. 9 %	0. 2 %- Po ints +
E B I T	2 0. 4	1 4. 9	3 6. 9 % +
E B I T m in arg	1 6. 6 %	1 5. 9 %	0. 7 %- Po ints +
Ear ing fter ( inu ing ion ) tax t t n s a es con op era s	1 5. 0	1 0. 4	4 4. 2 % +
Ne f it * t p ro	1 5. 0	6 8. 7	-
Ear ing har bas ic ( in € ), n s p er s e, inu ing ion t t con op era s	0. 7 8	0. 5 4	4 4. 4 % +

in € m i l l ion	Q 1 2 0 2 5	Q 1 2 0 2 4	C han g e
Ba lan hee d Ca h f low t a ce s n s
Eq ity u	2 9 2. 9	2 4 1. 1	2 1. 5 % +
Eq ity io rat u	5 7. 1 %	5 8. 0 %	-0. 9 %- Po ints
Ba lan hee t to ta l ce s	3. 5 1 4	4 1 5. 5	2 3. 6 % +
Ne h t ca s	1 3 0. 0	1 0 2. 4	2 7. 0 % +
Fre h f low e c as	8. 9	-0. 4	-
Fre h f low l * tot e c as a	8. 9	7 0. 1	-
Fur her key f ig t ure s
Inv est nts me	1. 7	1. 2	4 1. 7 % +
Inv io est nt r at me	1. 4 %	1. 3 %	0. 1 %- Po ints +
De iat ion p rec	1. 9	1. 8	5. 6 % +
3 Em loy f Ma h 1 p ees as o rc	0 9 1, 5	2 3 1, 7	8. 1 5 % +

* Including discontinued operations

Content

Interim statement for the 1st quarter of 2025

B i d l t s s s u n e e v e o p m e n	4
B i d l i h t t t u s n e s s e v e o p m e n n e s e g m e n s	5
O l k t u o o	7

Financial Report

C S l i d t d t t t f i ( I F R ) o n s o a e s a e m e n o n c o m e	8
S S t t t f h i i ( I F R ) a e m e n o c o m p r e e n s v e n c o m e	9
C l i d d b l h ( I F R S ) t t o n s o a e a a n c e s e e	1 0
C l i d d f h f l ( I F R S ) t t t t o n s o a e s a e m e n o c a s o w	1 2
C l i d d f h h l d ' i ( I F R S ) t t t t t o n s o a e s a e m e n o s a r e o e r s e q u y	1 4
S i ( I F R S ) t t e g m e n r e p o r n g	1 5
E i h a r n n g s p e r s a r e	8 1

Financial Calendar / Contact / imprint 19

"We have started 2025 with great momentum and continued our growth trajectory with a 31.8% increase in sales in the first quarter compared to the same quarter of the previous year. We currently expect to achieve our 2025 targets. At the same time, the announcement of far-reaching tariffs by the US government is creating a high level of uncertainty, particularly with regard to the development of the global economy, which can have an impact on demand for semiconductors. This in turn affects the willingness of our customers to invest, who need clear and reliable economic policy conditions for their investment decisions. We are closely monitoring the situation and improve our ability to respond quickly and flexibly to changing circumstances."

Interim Statement

for the period from January 1 to March 31, 2025

Business development

Overall, SUSS started the 2025 financial year with positive business development. The previous year's growth trajectory continued with a 31.8% increase in sales in the first quarter compared to the first quarter of the previous year to € 123.2 million (previous year: € 93.5 million). Gross profit improved by € 10.1 million to € 46.7 million (previous year: € 36.6 million), with the gross profit margin declining slightly to 37.9 % (previous year: 39.1 %). At € 20.4 million, EBIT in the reporting period was significantly higher than the previous year's figure of € 14.9 million. The EBIT margin improved accordingly by 0.7 percentage points to 16.6 % (previous year: 15.9 %).

Following the record order intake of € 147.5 million in the fourth quarter of 2024, incoming orders amounted to € 88.1 million in the first three months of this financial year. This development came as no surprise, as new business between October and December 2024 already included orders that we had not actually expected until the start of 2025. Due to this pull-forward effect, the order intake in the first quarter was below the level of the previous year's figure of € 98.3 million. While incoming orders in the Photomask Solutions segment were on a par with the previous year at € 33.7 million, orders worth € 54.3 million in the Advanced Backend Solutions segment were not able to match the comparable quarter of the previous year (€ 64.6 million), although demand for UV projection scanners for the manufacturing of AI chip modules in particular remained very high.

Our order book amounted to € 392.7 million at the end of the reporting period, down on the previous year's figure of € 456.9 million. The vast majority of the order book is scheduled for manufacturing and revenue recognition in the remainder of 2025.

In the reporting period from January to March 2025, sales increased by € 29.7 million or 31.8% to € 123.2 million and were therefore significantly higher than the previous year's figure of € 93.5 million. Encouragingly, both segments contributed to this growth. While sales in the Advanced Backend Solutions segment rose by 47.0 % due to strong, AI-related growth in the Bonding Systems product line, sales in the Photomask Solutions segment climbed by 8.6 %.

We also significantly increased gross profit by € 10.1 million to € 46.7 million (previous year: € 36.6 million). However, the gross profit margin of 37.9 % was below the forecast range of 39 to 41 % for the 2025 financial year and below the comparable previous-year figure of 39.1 %, as the margin trend in the Advanced Backend Solutions segment declined due to a change in the customer and product mix as well as start-up and training costs in Taiwan, mainly for UV projection scanners.

Selling expenses increased to € 6.5 million in the first three months of 2025 (previous year: € 5.5 million). We increased research and development expenses by € 1.7 million to € 10.9 million in the reporting period (previous year: € 9.2 million). The R&D ratio, i.e. the ratio of expenditure on research and development to sales, fell to 8.8 % (previous year: 9.8 %) due to the significant growth in sales. Our administrative expenses increased to € 9.6 million in the first quarter of 2025 (previous year: € 7.0 million), mainly due to higher personnel expenses based on an increased number of employees, higher IT expenses as a result of increased license fees and project costs, and in connection with ESG-related requirements, including the strengthening of governance functions. In total, selling, administrative and research and development expenses increased by 24.4 % to € 27.0 million (previous year: € 21.7 million) and therefore at a slower rate than sales growth.

In the reporting period, the balance of other operating income and other operating expenses was slightly positive. It amounted to € 0.7 million (previous year: € 0.0 million).

EBIT rose to € 20.4 million in the first quarter of the 2025 financial year (previous year: € 14.9 million), in particular due to the increase in gross profit. The EBIT margin improved accordingly by 0.7 percentage points to 16.6% (previous year: 15.9%) and was therefore at the upper end of the forecast range of 15 to 17% for the 2025 financial year.

The financial result increased slightly in the year to date to € 0.5 million (previous year: € 0.4 million) due to higher interest income.

As a result of the first three months of the 2025 financial year, the SUSS Group achieved a net profit for the period of € 15.0 million. The comparable previous year's figure was the result from continuing operations in the amount of € 10.4 million. The previous year's net profit for the period also included the sale of SUSS MicroOptics S.A. and therefore amounted to € 68.7 million in total.

Business development in the key regions

Geographically, the Asia/Pacific region is our largest sales market. After three months in the 2025 financial year, it accounted for 78.7% of incoming orders (previous year: 80.6%). Sales in this region amounted to € 103.0 million, contributing 83.6% (previous year: 86.9%) to Group sales. Taiwan and China accounted for the largest shares of both order intake and sales.

Business development in the segments

Segment Advanced Backend Solutions

The Advanced Backend Solutions segment bundles the development, manufacture and sale of the Imaging Systems (mask aligners and UV projection scanners), Coating Systems (coaters/developers and systems for inkjet coating processes) and Bonding Systems (temporary and permanent bonders) product lines. These product lines are manufactured in Germany at the Garching near Munich and Sternenfels sites and in Taiwan at the Hsinchu site. The main target market for this segment is the advanced backend of the semiconductor industry.

In the first three months of 2025, we generated order intake of € 54.3 million in the Advanced Backend Solutions segment. A key driver were further orders for our UV projection scanner, which is used in the leading packaging process for AI chip modules. Compared to the same period of the previous year, order intake was down 15.9% overall. It should be noted that the extraordinarily high order intake of € 102.1 million in the fourth quarter of 2024 already included orders that we had not expected until the first quarter of 2025.

Segment Advanced Backend Solutions

in € m i l l ion	Q 1 2 0 2 5	Q 1 2 0 2 4
Or der inta ke	5 4. 3	6 4. 6
Or der boo k	2 4 2. 4	2 9 4. 8
Sa les	8 2. 9	5 6. 4
Gro f it ss p ro	3 0. 4	2 5. 1
Gro f it m in ss p ro arg	3 6. 7 %	4 4. 5 %
E B I T	9. 7	7. 2
E B I T m in arg	1 1. 7 %	1 2. 8 %

The order book in the Advanced Backend Solutions segment amounted to € 242.4 million as of March 31, 2025 and was below the figure of € 294.8 million as of the reporting date for the first quarter of 2024 due to the strong sales development in previous quarters.

Segment sales increased significantly by € 26.5 million or 47.0% to € 82.9 million in the first quarter of 2025 (previous year: € 56.4 million). The sales growth was mainly attributable to the Bonding Systems product line, where the execution of AI-related orders for temporary bonding solutions continued as planned. Sales in the Imaging and Coating Systems product lines were roughly on par with the previous year.

The gross profit margin in the Advanced Backend Solutions segment fell to 36.7% in the first three months of 2025 (Q1 2024: 44.5%; full year 2024: 42.2%). The decline is mainly due to a change in the product and customer mix as well as start-up and training costs in Taiwan, mainly for the manufacturing of UV projection scanners.

EBIT in the segment increased from € 25.1 million to € 30.4 million in the first quarter of 2025 due to the higher gross profit. The EBIT margin in the Advanced Backend Solutions segment was 11.7%, compared to 12.8% in the same period of the previous year.

Segment Photomask Solutions

The Photomask Solutions segment comprises the development, manufacture and sale of solutions that specialize in the cleaning and processing of photomasks, primarily in the front end of semiconductor production.

Order intake in the Photomask Solutions segment in the first quarter of 2025 was exactly on par with the previous year's figure of € 33.7 million. The order book of € 150.4 million as of 31 March 2025 remains very high and will ensure full capacity utilization of production in this area throughout the course of this year, as planned.

Segment Photomask Solutions

in € m i l l ion	Q 1 2 0 2 5	Q 1 2 0 2 4
Or der inta ke	3 3. 7	3 3. 7
Or der boo k	0. 1 5 4	6 2. 1 1
Sa les	4 0. 3	3 7. 1
Gro f it ss p ro	1 6. 2	1 2. 2
Gro f it m in ss p ro arg	4 0. 2 %	3 2. 9 %
E B I T	1 3. 2	8. 2
E B I T m in arg	3 2. 8 %	2 2. 1 %

The Photomask Solutions segment achieved an increase in turnover of € 3.2 million or 8.6% to € 40.3 million in the first three months of the current year. The accelerated execution of orders that we received in previous quarters thus continued.

The gross profit margin improved significantly to 40.2% in the first quarter of 2025 (Q1 2024: 32.9%; full year 2024: 36.1%), mainly due to a favorable product and customer mix as well as the higher sales volume. As revenue in this segment is made up of a rather low volume of tools with relatively high sales prices, the margin trend is subject to greater fluctuations when there are changes in the product and customer mix.

Segment EBIT increased noticeably from € 8.2 million to € 13.2 million in the first quarter of 2025 due to the significantly higher gross profit. The EBIT margin thus improved from 22.1% to 32.8%.

Central Group Functions

The Central Group Functions segment includes the expenses and income of the central Group functions that cannot be allocated at segment level. The segment recorded EBIT of € -2.5 million in the first quarter of 2025 (previous year: € 58.4 million). In the previous year, the segment EBIT included extraordinary income from the sale of the MicroOptics segment.

Assets and financial position

SUSS' total assets amounted to € 513.4 million as of the reporting date and were therefore higher than the figure of € 500.9 million as of December 31, 2024. Equity increased to € 292.9 million in the first quarter of 2025 (December 31, 2024: € 279.7 million) due to the positive overall result. The equity ratio improved accordingly by 1.2 percentage points to 57.1 % in the first quarter.

Cash and cash equivalents increased to € 143.7 million (December 31, 2024: € 136.2 million).

After the balance sheet date, on April 1, 2025, we took over our new production site in Zhubei, Taiwan. We will now prepare this site in the coming months for the start of production in the second half of 2025. The right-of-use assets and the lease liability will be recognized in accordance with IFRS 16 as of April 1, 2025 in the amount of around € 43 million.

Cash flow

Free cash flow, defined as cash flow from operating activities less cash flow from investing activities adjusted for the effect of the acquisition and disposal of securities, amounted to € 8.9 million in the first quarter of 2025. The comparable figure for the previous year was € -0.4 million.

Cash flow from operating activities improved significantly in the reporting period compared to the first quarter of the previous year to € 10.6 million (previous year's figure from continuing operations: € 0.8 million). Compared to the same quarter of the previous year, lower additions to inventories of € -6.6 million (previous year: € -12.7 million) and the decrease in contract assets of € 7.9 million (previous year: € 0.3 million) had a positive effect. This was offset by the increase in other assets due to higher prepayments and advance payments in the reporting period with an effect of € -8.1 million (previous year: € -1.4 million) and the change in tax receivables and tax liabilities, which amounted to € -4.1 million (previous year: € 4.2 million).

Risks and opportunities of future development

In the reporting period, the assessment of risks from legal changes and, in particular, from trade barriers, especially in the form of tariffs, changed compared to the presentation of the risk and opportunity report in the 2024 Annual Report. Following the announcement of far-reaching tariffs by the government of the United States of America, we have reassessed the tariffs risks. Even after implementing suitable measures to better identify and reduce the impact of the risk, we now rate the probability of occurrence of the risk as "high". We rate the amount of loss as "severe". Overall, the risk from tariffs is therefore rated as "high". The fundamental assessment of the risk is independent of short-term political developments such as the temporary suspension of previously announced tariffs.

For a further description of the general economic and geopolitical risks as well as the industry- and market-specific risks, please refer to the presentation in the risk and opportunity report in the combined management report in the 2024 Annual Report.

Outlook

Our outlook after the first quarter of the 2025 financial year paints a mixed picture. In general, the current business trend remains positive. With sales of € 123.2 million, we have achieved very significant growth compared to the previous year. The gross profit margin of 37.9% achieved in the first quarter of 2025 and the EBIT margin of 16.6% are close to or within the forecast ranges defined for 2025 as a whole. At € 88.1 million, order intake in the first quarter of 2025 was solid following the exceptionally strong fourth quarter of 2024. The order book of € 392.7 million and the fact that we have not yet seen any substantial postponements or even cancellations of customer projects provide good visibility for the rest of the year.

However, the risks to the outlook have increased, as described above. Uncertainty about the development of the global economy and thus also about the development of global demand for semiconductors has increased significantly. It cannot be ruled out that the far-reaching tariff announcements by the United States of America will cause our customers to be reluctant to invest, at least temporarily, which could also affect SUSS as a result. Accordingly, we are more cautious about the development of the market for semiconductor equipment than we were at the beginning of the year. The impact of tariffs on deliveries to the United States of America is directly noticeable. The implementation or even further tightening of the announced tariffs and renewed drastic currency fluctuations could also have a negative impact on our business.

For 2 0 2 5 t eca s
Per form in d icat anc e or	For 2 0 2 5 t eca s	Res lt 2 0 2 4 u
Sa les	€ 0 – 1 0 m 4 7 5 i l l ion	€ 6, 1 m 4 4 i l l ion
Gro f it m in ss p ro arg	3 9 – 4 1 %	4 0, 0 %
E B I T m in arg	1 5 – 1 7 %	1 6, 8 %

For our outlook, this means that, based on our current assessment, we continue to expect to achieve the targets we have set for 2025. We are therefore confirming our forecast at this time. The key assumptions of this forecast are unchanged from those in the 2024 Annual Report, where we had already identified substantial project postponements and order cancellations as a risk to our outlook, but had not included them in the forecast. The tariffs announced in April 2025 for exports to the United States of America and a significant additional change in exchange rates, particularly against the US dollar, could have a negative impact on our earnings development and are also not currently included in the forecast for the 2025 financial year.

Forward-looking statements

This quarterly statement contains statements and forecasts relating to future developments of the SUSS Group and its companies. The forecasts represent estimates that we have made on the basis of all the information available to us at the present time. If the assumptions on which the forecasts are based do not materialize or unforeseen events occur that affect the earnings situation, the actual results may differ from those currently expected.

Garching, Germany, May 5, 2025

Signed

Burkhardt Frick CEO Dr. Cornelia Ballwießer CFO Dr. Thomas Rohe

COO

Consolidated statement of income (IFRS)

for the period from January 1 to March 31, 2025

in € hou d t san	0 0 2 0 2 1 / 1 / 5 0 3 / 3 1 / 2 0 2 5 -	0 0 2 0 2 1 / 1 / 4 0 3 / 3 1 / 2 0 2 4 -
Sa les	2 3, 9 3 1 1	9 3, 0 3 5
Co f sa les st o	-7 6, 4 6 0	-5 6, 9 2 6
Gro f i t ss p ro	6, 3 3 4 7	3 6, 5 7 7
Se l l ing sts co	-6, 4 8 4	-5, 5 2 6
Res h a d dev lop nt c ost ear c n e me s	-1 0, 8 8 9	-9, 1 9 1
A dm in istr ion at sts co	-9, 6 4 6	-6, 9 9 9
Ot her ing inc t op era om e	2, 2 4 4	1, 0 5 5
Ot her ing t op era ex p ens es	-1, 5 8 3	-1, 0 5 5
Ne t inc fro t ion ( E B I T ) om e m o p era s	2 0, 3 7 5	1 4, 8 6 1
F ina ia l inc nc om e	6 3 5	4 8 1
F ina ia l ex nc p ens es	-9 1	-1 0 0
F ina ia l re l t nc su	5 4 4	3 8 1
Pro f i be for ( inu ing ion ) t tax t t e es con op era s	2 0, 9 1 9	1 5, 2 4 2
Inc e ta om xes	-5, 9 6 0	-4, 8 5 4
Pro f i t ( t inu ing t ion ) co n op era s	9 9 1 4, 5	0, 3 8 8 1
Pro f i t ( d isc t inu d o t ion ) on e p era s	0	5 8, 3 2 7

in € t hou d san	0 1 / 0 1 / 2 0 2 5 0 3 / 3 1 / 2 0 2 5 -	0 1 / 0 1 / 2 0 2 4 0 3 / 3 1 / 2 0 2 4 -
Ne f i t p t ro	1 4, 9 5 9	6 8, 7 1 5
T her f s har ho l der f S U S S M icro Tec S E eo e s o	1 4, 9 5 9	6 8, 7 1 5
T her f no l l ing inte ont ts eo n-c ro res	0	0
Ear ing har inu ing ion ( bas ic ) in € t t n s p er s e c on op era s	0. 7 8	0. 5 4
Ear ing har inu ing ion ( d i lu d ) in € t t te n s p er s e c on op era s	0. 7 8	0. 5 4

Statement of comprehensive income (IFRS)

for the period from January 1 to March 31, 2025

in € hou d t san	0 1 / 0 1 / 2 0 2 5 0 3 / 3 1 / 2 0 2 5 -	0 1 / 0 1 / 2 0 2 4 0 3 / 3 1 / 2 0 2 4 -
Ne f i t p t ro	1 4, 9 5 9	6 8, 7 1 5
I tem t ha t a t re las i f ie d to f i t a d los in fu tur io ds s re n o c s p ro n s e p er
Act ia l g ins / los from de f ine d ben f it p ion lan uar a ses e ens p s ( fro he d isp l o f los from he le o f su bs i d iar ies ) m t t osa ses sa	-1	1, 6 5 0
Tax f fec ( from he d isp l o f los from he le o f su bs i d iar ies ) ts t t e osa ses sa	0	-2 0 6
O t her inc f ter tax for i tem t ha t a t re las i f ie d a om e a s re no c s s inc an exp ens e o om e r	-1	1, 4 4 4
Item hat las i f ie d in late io ds s t are rec s r p er
For ig d j ust nt e n c urre ncy a me
ins d los is ing in t he t p io d g a an ses ar cur ren er	-1, 7 7 7	9 6 1
les fers he inc s tr to t tate nt ans om e s me	0	4, 4 7 1
For ig d j l ust nt t ota e n c urre ncy a me	-1, 7 7 7	-4, 2 7 5
O her inc f for i ha las i f ie d a t ter tax tem t t a e a s s s a ens om re rec n e xp e o r inc in fu tur io ds om e e p er	-1, 7 7 7	-4, 2 7 5
O t her hen ive inc ( f ter tax ) co mp re s om e a	-1, 7 7 8	-2, 8 3 1
To l o her hen ive inc ta t co mp re s om e	1 3, 1 8 1	6 5, 8 8 4
her f s har ho l der f S U S S M icro Tec t eo e s o	1 3, 1 8 1	6 5, 8 8 4
t her f no ont l l ing inte ts eo n-c ro res	0	0

Consolidated balance sheet (IFRS)

as of March 31, 2025

As ts se
in € t hou d san	0 3 / 3 1 / 2 0 2 5	1 2 / 3 1 / 2 0 2 4
No t as ts n-c urr en se
Inta i b le a ts ng sse	4, 2 6 0	4, 6 1 6
Go dw i l l o	1 8, 6 5 4	1 8, 6 3 1
Tan i b le a ts g sse	3 5, 2 6 7	3 3, 8 1 5
Ot her set as s	1, 0 7 7	8 4 5
De fer d ta ts re x a sse	6 8 0	6 9 7
No t as ts n-c urr en se	5 9, 8 3 0	5 8, 6 0 4
Cu As t ts rre n se
Inv ies ent or	2 1 7, 1 3 6	2 1 3, 9 7 1
Tra de iva b les rec e	1 5, 5 0 7	1 4, 8 6 1
Co ntra ct a ts sse	5 1, 0 2 0	5 8, 8 9 0
Ot her f ina ia l as set nc s	3 5 7	2 0 1, 4
Cu nt t ets rre ax ass	6 4	6 7
Ot her set as s	2 5, 5 4 3	1 7, 0 3 7
Ca h a d c h e iva len ts s n as q u	1 3, 3 4 7 4	1 3 6, 2 3 9
Cu t as ts rre n se	4 5 3, 5 4 1	4 4 2, 2 6 9
To l as ta ts se	5 1 3, 3 7 1	5 0 0, 8 7 3

Consolidated balance sheet (IFRS)

as of March 31, 2025

& L ia b i l i t ies har ho l de ' eq i ty s e rs u
in € t hou d san	0 3 / 3 1 / 2 0 2 5	1 2 / 3 1 / 2 0 2 4
Eq i ty u
Su bsc i be d c ita l r ap	1 9, 1 1 6	1 9, 1 1 6
Res erv es	2 7 7, 3 7 0	2 6 2, 4 1 1
Acc late d o her hen ive inc t um co mp re s om e u	-3, 5 5 9	-1, 7 8 1
Eq i ty u	2 9 2, 9 2 7	2 7 9, 7 4 6
Tot l eq ity i but b le t har ho l der f attr a u a o s e s o S U S S M icro Tec S E	2 9 2, 9 2 7	2 7 9, 7 4 6
No t l ia b i l i tes n-c urr en
Pen ion lan d s im i lar itm ent s p s a n com m s	1, 7 5 3	1, 8 0 0
Pro is ion v s	3, 9 1 1	3, 9 1 1
F ina ia l de bt nc	3, 7 5 0	4, 0 6 3
F ina ia l de bt from lea b l ig ion at nc se o s	6, 1 3 5	5, 7 0 8
Ot her f ina ia l l ia b i l it ies nc	1, 4 5 9	1, 4 6 7
Ot her l ia b i l it ies	8 2 0	8 2 0
De fer d ta l ia b i l it ies re x	2 4, 8 6 7	2 0, 8 4 7
No l ia b i l i ies t t n-c en urr	4 2, 6 9 5	3 8, 6 1 6

Liabilities&shareholders' equity

in € t hou d san	0 3 / 3 1 / 2 0 2 5	1 2 / 3 1 / 2 0 2 4
Cu l ia b i l i ies t t rre n
Pro is ion v s	4, 4 3 9	4, 2 2 5
Tax l ia b i l it ies	1 2, 4 0 8	2 0, 5 7 8
F ina ia l de bt nc	1, 2 7 3	1, 2 6 6
F ina ia l de bt from lea b l ig ion at nc se o s	2, 5 8 4	2, 2 5 8
Ot her f ina ia l l ia b i l it ies nc	1 4, 2 6 6	1 8, 0 7 8
Tra de b les p ay a	3 3, 9 6 6	3 1, 5 4 6
Co l ia b i l it ies ntra ct	1 0 1, 3 4 9	9 9, 4 4 3
Ot her l ia b i l it ies	6 7, 4 4	5, 1 1 7
Cu t l ia b i l i t ies rre n	1 7 7, 7 4 9	1 8 2, 5 1 1
To l l ia b i l i ies d s har ho l de 's e i ta t ty an e r q u	5 1 3, 3 7 1	5 0 0, 8 7 3

Consolidated statement of cash flow (IFRS)

for the period from January 1 to March 31, 2025

In € t hou d san	0 1 / 0 1 / 2 0 2 5 0 3 / 3 1 / 2 0 2 5 -	0 1 / 0 1 / 2 0 2 4 0 3 / 3 1 / 2 0 2 4 -
Ne f i t p t ro	1 4, 9 5 9	6 8, 7 1 5
A d j ust nts to i le n et inc / ( los ) to o t ing me rec onc om e s p era h f low cas s
Inc / ( los ) from d isc inu d o ion ( f ta ) ont t net om e s e p era s o xes	0	-5 8, 3 2 7
Am izat ion f inta i b le a ort ts o ng sse	4 0 0	3 8 2
De iat ion f ta i b le a ts p rec o ng sse	1, 5 0 4	1, 4 5 9
Pro f it / los d isp l o f inta i b le a d ta i b le a ts s o n osa ng n ng sse	0	1
C han f re inve ies nto g e o ser ves on r	2, 6 6 2	4 6 1
C han f re for ba d de bts g e o ser ves	-5 5	6 8
No h inte from inc f co i b le de bt t ex rt n-c as res p ens es rea se o nve	0	0
Ot her h e f fec ive inc d e t no n-c as om e a n xp ens es	-4 5 0	6 2 7
C han in inve ies nto g e r	-6, 6 4 9	-1 2, 7 2 7
C han in c ont t as set g e rac s	8 0 7, 7	3 8 4
C han in t de iva b les g e ra rec e	-7 7 4	3, 5 4 5
C han in o her t set g e as s	-8, 0 7 1	-1, 3 8 7
C han in p ion is ion g e ens p rov s	-5 1	-7 2
C han in t de b les g e ra p ay a	2, 5 4 0	3, 0 9 3
C han in c l ia b i l it ies ont t g e rac	1, 9 0 6	-1 0, 2 0 6

€ t In hou d san	0 1 / 0 1 / 2 0 2 5 0 3 3 2 0 2 / 1 / 5 -	0 1 / 0 1 / 2 0 2 4 0 3 3 2 0 2 / 1 / 4 -
C han in o her l ia b i l it ies d o her is ion t t g e an p rov s	-1, 0 3 1	6 1 1
C han in t d l ia b i l it ies ts a tax g e ax ass e n	-4, 1 3 0	4, 2 1 0
Ca h f low fro t ing t iv i t ies t inu ing t ion s m o p era ac - c on op era s	0, 6 3 0 1	8 0 1
Ca h f low fro ing iv i ies d isc inu d o ion t t t t t s m o p era ac on e p era s -	0	9 2 9
Ca h f low fro ing iv i ies l t t t to ta s m o p era ac -	1 0, 6 3 0	1, 7 3 0
D is bur for her i b le a ent ot tan ts sem s g sse	-1, 6 8 3	-1, 1 0 3
D is bur for inta i b le a ent ts sem s ng sse	-4 7	-6 9
Ca h o f low due inve it h in s hor ia l p ut to stm ent t-te s s s w rm com me rc ap er	0	-9, 7 8 3
Ca h inc due inve it h in s hor ia l p to stm ent t-te s om e s w rm com me rc ap er	0	9, 8 9 5
Ca h f low fro inv t ing t iv i t ies t inu ing t ion s m es ac - c on op era s	-1, 7 3 0	-1, 0 6 0
Ca h f low fro inv ing iv i ies d isc inu d o ion t t t t t s m es ac on e p era s -	0	6 9, 5 3 1
Ca h f low fro inv t ing t iv i t ies to ta l s m es ac -	-1, 7 3 0	6 8, 4 7 1

Continued on the next page▼

Continuation ▼

In € t hou d san	0 1 / 0 1 / 2 0 2 5 0 3 / 3 1 / 2 0 2 5 -	0 1 / 0 1 / 2 0 2 4 0 3 / 3 1 / 2 0 2 4 -
Rep nt o f ban k loa ay me ns	-3 1 3	-3 1 3
Rep f re l an d lea l ia b i l it ies nt o nta ay me se	-6 8 5	-6 0 8
C han in o her f ina ia l de bt t g e nc	7	4 7
Ca h f low fro f ina ing iv i ies inu ing ion t t t t ac era s m nc - c on op s	-9 9 1	-8 7 4
Ca h f low fro f ina ing t iv i t ies d isc t inu d o t ion s m nc ac on e p era s -	0	0
Ca h f low fro f ina ing iv i ies t t s m nc ac	-9 9 1	-8 7 4
A d j ust nts to fun ds d by han ate f luc tua t ion me cau se exc g e-r s	-4 1 4	-6 1
C han in c h a d c h e iva len ts g e as n as q u	7, 4 9 5	6 9, 2 6 6
Fun ds he beg inn ing f t he at t o ear y	1 3 6, 2 3 9	3 8, 7 5 6
Fun ds d o f he io d t e t a n p er	1 4 3. 7 3 4	1 0 8, 0 2 2
( her f ca h a d c h e iva len fro d isc inu d o ion ) t ts ont t eo s n as q u m e p era s	0	6 4 2
Ca h f low from ing iv it ies ( inu ing ion ) inc lu d ing t t t t s op era ac con op era s :
Inte i d dur ing he io d t p t res a p er	3 1	5 6
Inte t re ive d dur ing io d res ce p er	8 5 5	2 0 4
Tax i d dur ing he io d t es p a p er	8, 6 5 2	6 7 2

Consolidated statement of shareholders' equity (IFRS)

for the period from January 31 to March 31, 2025

				Ac la te cum u	d o t her hen ive co mp re s	inc om e
in € t hou d san	Su bsc i be d c ita l r ap	A d d it ion l a i d- in c ita l p a ap	Ear ing n s re ser ve	Rem f nt o eas ure me de f ine d ben f it p lan e s	De fer d ta re xes	For ig e n c urre ncy d j ust nts a me	Tot l eq ity i but b le attr a u a har ho l der f to s e s o S U S S M icro Tec S E
As f Jan 1, 2 0 2 4 o uar y	1 9, 1 1 6	5 5, 8 2 2	1 0 1, 5 0 2	-3, 2 7 8	6 3 8	2, 8 1 7	1 7 6, 6 1 7
Ne inc t om e			6 8, 7 1 5				6 8, 7 1 5
Ot her inc * om e				1, 6 5 0	-2 0 6	-4, 2 7 5	-2, 8 3 1
To ta l co hen ive inc mp re s om e			6 8, 7 1 5	1, 6 5 0	-2 0 6	-4, 2 7 5	6 5, 8 8 4
E f fec from d ive f a bs i d iary t stm ent su o			-1, 4 3 2				-1, 4 3 2
3 2 0 2 As f Ma h 1, 4 o rc	9, 6 1 1 1	8 2 2 5 5,	6 8, 8 1 7 5	6 2 8 -1,	3 2 4	8 -1, 4 5	2 0 6 9 4 1,
As f Jan 1, 2 0 2 5 o uar y	1 9, 1 1 6	5 5, 8 2 2	2 0 6, 5 9 0	-2, 0 6 5	5 4 8	-2 6 5	2 7 9, 7 4 6
Ne inc t om e			1 4, 9 5 9				1 4, 9 5 9
Ot her inc om e				-1	-	-1, 7 7 7	-1, 8 7 7
To ta l co hen ive inc mp re s om e			1 4, 9 5 9	-1	-	-1, 7 7 7	1 3, 1 8 1
As f Ma h 3 1, 2 0 2 5 o rc	1 9, 1 1 6	5 5, 8 2 2	2 2 1, 5 4 9	-2, 0 6 6	5 4 8	-2, 0 4 2	2 9 2, 9 2 7

Segment reporting (IFRS)

Se in for ion by bus ine t t t g me n ma ss seg me n
	A dva d Bac ken d nce So lut ion s		P hot k om as So lut ion s		* M icro Op ics t		Ce l Gro ntra up Fun ion ct s		Co l i dat ion nso E f fec ts		Tot l a
in € t hou d san	3 M / 2 0 2 5	3 M / 2 0 2 4	3 M / 2 0 2 5	3 M / 2 0 2 4	3 M / 2 0 2 5	3 M / 2 0 2 4	3 M / 2 0 2 5	3 M / 2 0 2 4	3 M / 2 0 2 5	3 M / 2 0 2 4	3 M / 2 0 2 5	3 M / 2 0 2 4
Ext l sa les ern a	8 2, 9 3 4	6, 2 5 4 7	0, 2 9 4 5	3 0 3 7, 7	-	3 2 9 1,	-	3			2 3, 9 3 1 1	9 8 3 2 4,
Inte l Sa les rna	-	-	-	-	-	-	-	-	-	-	-	-
To l Sa les ta	8 2, 9 3 4	5 6, 4 2 7	4 0, 2 5 9	3 7, 0 7 3	-	1, 3 2 9	-	3		-	1 2 3, 1 9 3	9 4, 8 3 2
Gro f it ss p ro	3 0, 4 1 6	2 5, 1 1 7	1 6, 1 7 5	1 2, 2 1 8	-	-5 5	1 4 2	-7 5 8			4 6, 7 3 3	3 6, 5 2 2
Gro f it m in ss p ro arg	3 6. 7 %	4 4. 5 %	4 0. 2 %	3 3. 0 %		-4. 1 %					3 7. 9 %	3 8. 5 %
Ot her / inc ( ) nt e net se g me xp ens es om e	-2 0, 7 0 3	-1 7, 8 7 6	-2, 9 8 9	-3, 9 8 5	-	-2 7 0	-2, 6 6 6	5 9, 1 6 0			-2 6, 3 5 8	3 7, 0 2 9
her f inte t nt c ost eo rse g me l loc ion ( ) at net a	-3, 6 9 1	-3, 9 4 4	-1, 4 5 7	0 8 -1, 1		-	0 6 5, 7	4, 5 5 7			-	-
her f ce l se ice f t ntra eo rv s o S U S S M icro Tec S E	-3, 6 1 9	-3, 4 4 9	-1, 4 5 7	-1, 1 0 8	-	-	5, 0 7 6	4, 5 5 7			-	-
Re l ( E B I T ) t p t su er s eg me n	9, 7 1 3	7, 2 4 1	1 3, 1 8 6	8, 2 3 3	-	-3 2 5	-2, 5 2 4	5 8, 4 0 2			2 0, 3 7 5	7 3, 5 5 1
E B I T m in arg	1 1. 7 %	1 2. 8 %	3 2. 8 %	2 2. 2 %		-2 4. 5 %					1 6. 5 %	7 7. 6 %
Ear ing be fore tax n s es	9, 7 0 2	7, 2 2 9	1 3, 1 8 6	8, 2 3 2	-	-3 2 5	-1, 9 6 9	5 8, 7 9 6			2 0, 9 1 9	7 3, 9 3 2
S ig i f ian h item t no n n-c as s	-2, 1 5 1	-1, 4 5 9	-4 7 9	7 6	-	-	2 7	-1 4			-2, 6 0 3	-1, 3 9 7

* Discontinued operations

Segment reporting (IFRS)

Continuation ▼

Se in for ion by bus ine t t t g me n ma ss seg me n
	A dva d Bac ken d nce So lut ion s		P hot k om as So lut ion s		* M icro Op ics t		Ce l Gro ntra up Fun ion ct s		Co l i dat ion nso E f fec ts		Tot l a
in € t hou d san	3 M / 2 0 2 5	3 M / 2 0 2 4	3 M / 2 0 2 5	3 M / 2 0 2 4	3 M / 2 0 2 5	3 M / 2 0 2 4	3 M / 2 0 2 5	3 M / 2 0 2 4	3 M / 2 0 2 5	3 M / 2 0 2 4	3 M / 2 0 2 5	3 M / 2 0 2 4
Seg nt a ts me sse	2 5 1, 4 8 5	2 0 1, 9 8 1	7 2, 6 2 7	6 2, 8 3 2	-	-	1 7, 6 2 5	1 8, 4 5 9		-	3 4 1, 7 3 7	2 8 3, 2 7 2
her f g dw i l l t eo oo	1 8, 5 4 6	1 8, 5 5 2									1 8, 5 4 6	1 8, 5 5 2
Un l loc d a ate ts a sse											1 7 1, 6 3 4	1 3 2, 2 1 5
To l as ta ts se											5 1 3, 3 7 1	4 1 5, 4 8 7
Seg l ia b i l it ies nt me	-1 0 0, 1 9 2	-7 4, 9 9 6	-4 8, 6 6 3	-4 4, 9 8 3	-	-	-5, 5 6 7	-3, 9 7 3		-	-1 5 4, 4 2 2	-1 2 3, 9 5 2
Un l loc ate d l ia b i l it ies a											-6 6, 0 2 2	0, 6 6 -5 4
To l l ia b i l i ies ta t											-2 2 0, 4 4 4	-1 7 4, 4 1 8
De iat ion d a rt izat ion p rec an mo	6 6 1, 1	9 2 5	2 6 5	8 4 5	-	-	8 2 4	8 4 5			9 0 1, 4	8 1, 4 1
her f sc he du le d t eo	1, 1 6 6	9 2 5	2 5 6	4 5 8	-	-	4 8 2	4 5 8			1, 9 0 4	1, 8 4 1
her f imp irm los t ent eo a s	-	-	-	-	-	-	-	-			-	-
Ca i ta l ex d i tur p p en e	9 6 1	7 4 9	3 5 3	2 5 0	-	-	4 1 6	1 7 3			1, 7 3 0	1, 1 7 2
3 Em loy f Ma h 1 p ee s a s o rc	9 1, 1 1	9 9 7	2 6 0	2 3 3	-	-	8 5	3 4			0 9 1, 5	2 3 1, 7

* Discontinued operations

Segment reporting (IFRS)

Segment information by region

	Sa	les	Ca ita l ex p	d itur p en e	Ass ets ( it hou Go dw i l l ) t w o
€ in t hou d san	3 M / 2 0 2 5	3 M / 2 0 2 4 *	3 M / 2 0 2 5	3 M / 2 0 2 4 *	3 M / 2 0 2 5	3 M / 2 0 2 4 *
E M E A	1 1, 5 7 8	7, 5 1 4	1, 3 3 8	7 4 3	2 8 4, 2 5 6	2 3 8, 9 1 7
No h Am ica rt er	8, 5 8 7	4, 8 6 2	8	-	4, 9 8 1	3, 0 5 5
As ia a d Pac i f ic n	1 0 3, 0 2 8	8 2, 4 5 6	3 8 4	4 2 9	3 7, 8 2 8	2 2, 7 4 8
Co l i dat ion f fec ts nso e					-3, 8 7 4
To ta l	1 2 3, 1 9 3	9 4, 8 3 2	1, 7 3 0	1, 1 7 2	3 2 3, 1 9 1	2 6 4, 7 2 0

* Including discontinued operations.

Earnings per share

	0 1 / 0 1 0 3 / 3 -	/ 2 0 2 5 1 / 2 0 2 5	0 1 / 0 1 / 2 0 2 4 0 3 / 3 1 / 2 0 2 4 -
in € hou d t san	Tot l am t a oun	Ear ing har s p er s n e in € ( bas ic )	Tot l am t a oun	Ear ing har s p er s n e in € ( bas ic )
Ear ing fter ( inu ing ion ) tax t t n s a es con op era s f w h ic h s har ho l der f S U S S M icro Tec S E o e s o	1 4, 9 5 9	0. 7 8	1 0, 3 8 8	0. 5 4
Ear ing fter ( d isc inu d o ion ) tax ont t n s a es e p era s f w h ic h s har ho l der f S U S S M icro Tec S E o e s o	0	0. 0 0	8, 3 2 5 7	3. 0 5
Ne t p f it / ( los ) ro s f w h ic h s har ho l der f S U S S M icro Tec S E o e s o	1 4, 9 5 9	0. 7 8	6 8, 7 1 5	3. 5 9
We ig hte d a ber f ou d ing har tsta ver ag e n um o n s es	1 9, 1 1 5, 5 3 8	0. 7 8	1 9, 1 1 5, 5 3 8	0. 5 4

There were no dilution effects in the reporting period presented.

Financial Calendar 2025

Qu ly S f Ma h 3 1, 2 0 2 5 ter ta tem t a ar en s o rc	Ma 8, 2 0 2 5 y
An l Ge l Me ing t nu a ne ra e	Ju 3, 2 0 2 5 ne
Ha l f-y F ina ia l Re t ea r nc p or	2 0 2 Au 7, 5 t g us
Qu ly S f Se be 3 0, 2 0 2 5 ter ta tem t a tem ar en s o p r	No be 6, 2 0 2 5 ve m r
Ca i l Ma ke Da 2 0 2 5, Ga h ing Ge ta ts p r y rc rm an y ,	No be 1 7, 2 0 2 5 ve m r

Contact

SUSS MicroTec SE Schleissheimer Straße 90 85748 Garching, Germany

Email: info@suss.com

Investor Relations Phone: +49 89 32007-151 / -161

Email: ir@suss.com

Forward-looking statements: This Quarterly Statement includes forward-looking statements. Forward-looking statements do not present historical facts but include statements about expectations and the views of the management of SUSS MicroTec SE. These statements are based on current plans, estimates, and forecasts of the Company's management. Investors should not place undue reliance on these statements. Forward-looking statements are to be understood in the context of the time at which they were made. The Company does not assume any obligation to update the forward-looking statements included in this report as a result of new information or future events. The Company's obligation to comply with its statutory responsibilities regarding information and reporting remains unaffected. Forward-looking statements always involve risks and uncertainties. A large number of factors that are described in this report could cause actual events to deviate substantially from the forward-looking statements included in this report.

suss.com